Keywords: gsk, settles, augmentin, antitrust, litigation, glaxosmithkline, says

GSK settles US Augmentin antitrust litigation

Article | 19 July 2004

Print This

GlaxoSmithKline says that it has agreed to settle US antitrust casesinvolving the antibiotic product Augmentin (clavulanate).

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in